Life Technologies reported $92.87M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Ardelyx USD 240.77M 240.74M Jun/2025
Biogen USD 146.6M 146.5M Jun/2025
Bristol-Myers Squibb USD 2.04B 1.74B Jun/2025
Cipla INR 1.62B 100K Mar/2025
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 93.54M 93.29M Jun/2025
CSL USD 576M 19M Dec/2024
Galapagos EUR 65.9M 228.04M Jun/2025
GlaxoSmithKline GBP 4.15B 2.8B Jun/2025
Grifols EUR 119.6M 0 Dec/2024
Life Technologies USD 92.87M 92.79M Jun/2025
Novartis USD 793M 0 Dec/2024
Roche Holding CHF 107M 0 Jun/2024
United Therapeutics USD 45.22M 44.42M Jun/2025